Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 24;1(1):H103-H109.
doi: 10.1530/VB-19-0021. eCollection 2019.

Nanotechnology and stem cells in vascular biology

Tomasz Jadczyk  1   2 , Guido Caluori  1   3 , Wojciech Wojakowski  1 , Zdenek Starek  2   4
Affiliations
Review

Nanotechnology and stem cells in vascular biology

Tomasz Jadczyk et al. Vasc Biol. .

Abstract

Nanotechnology and stem cells are one of the most promising strategies for clinical medicine applications. The article provides an up-to-date view on advances in the field of regenerative and targeted vascular therapies describing a molecular design (propulsion mechanism, composition, target identification) and applications of nanorobots. Stem cell paragraph presents current clinical application of various cell types involved in vascular biology including mesenchymal stem cells, very small embryonic-like stem cells, induced pluripotent stem cells, mononuclear stem cells, amniotic fluid-derived stem cells and endothelial progenitor cells. A possible bridging between the two fields is also envisioned, where bio-inspired, safe, long-lasting nanorobots can fully target the cellular specific cues and even drive vascular process in a timely manner.

Keywords: nanorobots; nanotechnology; stem cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this review.

Figures

Figure 1
Figure 1
The scope of nanotechnology and stem cell applications in human vascular diseases.
See this image and copyright information in PMC

References

    1. Jadczyk T, Bryndza Tfaily E, Mishra S, Jedrzejek M, Boloz M, Padmanabhan P, Wojakowski W, Starek Z, Martel S, Gulyas B. Innovative Diagnostics and Treatment: Nanorobotics and Stem Cells. Springer Briefs in Applied Science and Technology 2017. Singapore: Springer; Singapore; (10.1007/978-981-10-4527-1) - DOI
    1. Wamala I, Roche ET, Pigula FA. The use of soft robotics in cardiovascular therapy. Expert Review of Cardiovascular Therapy 2017. 767–774. (10.1080/14779072.2017.1366313) - DOI - PubMed
    1. Paliwal R, Babu RJ, Palakurthi S. Nanomedicine scale-up technologies: feasibilities and challenges. AAPS PharmSciTech 2014. 1527–1534. (10.1208/s12249-014-0177-9) - DOI - PMC - PubMed
    1. Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharmaceutical Research 2016. 2373–2387. (10.1007/s11095-016-1958-5) - DOI - PubMed
    1. Martel S. Swimming microorganisms acting as nanorobots versus artificial nanorobotic agents: a perspective view from an historical retrospective on the future of medical nanorobotics in the largest known three-dimensional biomicrofluidic networks. Biomicrofluidics 2016. 021301 (10.1063/1.4945734) - DOI - PMC - PubMed

LinkOut - more resources